Mizolastine
Top View
- Mizolastine/Pheniramine 587
- Antihistamine Effects and Safety of Fexofenadine: a Systematic Review
- Product List
- (Therapeutic Products) Regulations 2015
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- Antihistamines and Driving-Related Behavior: a Review of the Evidence for Impairment by First- Versus Second-Generation H1-Antagonists
- Previous Versions
- Antihistamines in Drivers, Aircrew and Occupations of Risk
- Patient Instruction CONSENT FORM for ALLERGY SKIN TESTING Skin Test: Skin Tests Are Methods of Testing for Allergic Antibodies
- Questions from Committee
- Fexofenadine-Induced Urticaria Ann Dermatol Vol
- Mastel® Mizolastine
- (12) United States Patent (10) Patent No.: US 7,927,600 B2 Loria Et Al
- Protocol for MEDA Pharmaceuticals the Burden of Rhinitis in Australia
- Pheniramine Maleate
- Could Histamine H1 Receptor Antagonists Be Used for Treating COVID-19?
- Brief Report
- Ocular Allergy